Close

Analyst Ratings for BioXcel Therapeutics (BTAI) [Sells]

BTAI Rating Summary

BTAI Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BTAI
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $6.08 (+115.7%) * Over Last 12-Mos
Rating Score: 5 / 10   Percentile Rank: 53%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
Like BTAI Ratings? Also take a look at STX, BAX, IBRX, SMCI

BTAI Ratings News